Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03510156 · ClinicalTrials.gov registry record · NA
Treatment of Disruptive Behaviors in Fragile X Syndrome
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03510156: Completed NA study, sponsored by Stanford University.
NCT03510156 is a NA study that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03510156, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Disruptive behaviors such as self-injury, aggression, and property destruction pose significant health-related issues to children diagnosed with fragile X syndrome (FXS), impacting the child's quality of life and causing significant distress to families. Access to appropriate treatment for families is severely limited by factors such as cost of care, shortages of qualified treatment providers, and geographic spread of children with FXS across the country. To address these potential issues, the effectiveness of administering a standardized function-based behavioral treatment for problem behaviors in FXS will be evaluated using telemedicine. The proposed study intervention therefore offers a tremendous step forward in clinical research both in the field of FXS and in the field of developmental disabilities more broadly, and thus will have a significant impact on public health.
Interventions
- BEHAVIORAL Behavior analytic treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-07 |
| Est. Completion | 2022-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03510156
The ClinicalTrials.gov registry entry for NCT03510156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavior analytic treatment is the first listed.
NCT03510156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03510156 about?
NCT03510156 is a clinical study titled "Treatment of Disruptive Behaviors in Fragile X Syndrome". Disruptive behaviors such as self-injury, aggression, and property destruction pose significant health-related issues to children diagnosed with fragile X syndrome (FXS), impacting the child's quality of life and causing significant distress to families. Access to appropriate treatment for families...
What is the current status of trial NCT03510156?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-07. Estimated completion is 2022-03.
What interventions are being tested in trial NCT03510156?
The interventions under investigation include: Behavior analytic treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03510156?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.